Keefe Bruyette raised the firm’s price target on Lemonade (LMND) to $40 from $35 and keeps an Underperform rating on the shares. The firm sees modest downside to consensus estimates in 2026, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LMND: